BIOSOLAR, INC. (OTCMKTS:BSRC) Files An 8-K Changes in Registrant’s Certifying Accountant

BIOSOLAR, INC. (OTCMKTS:BSRC) Files An 8-K Changes in Registrant’s Certifying Accountant
Item 4.01 Change in Registrant’s Certifying Accountant

Resignation of Liggett & Webb P.A.

On December 2 2019, Liggett & Webb, P.A. (“L&W”) resigned as the independent registered public accounting firm of BioSolar, Inc. (the “Company”).

During the fiscal years ended December 31, 2018 and December 31, 2017, L&W’s reports on the Company’s financial statements did not contain an adverse opinion or disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope or accounting principles, except that the report was modified as to the Company’s ability to continue as a going concern.

During the fiscal years ended December 31, 2018 and December 31, 2017 and the subsequent interim period through December 2, 2019, (i) there were no disagreements between the Company and L&W on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of L&W, would have caused L&W to make reference to the subject matter of the disagreement in connection with its report on the Company’s financial statements; and (ii) there were no reportable events as described in paragraph (a)(1)(v) of Item 304 of Regulation S-K.

On December 3, 2019, the Company provided L&W with a copy of the disclosures it is making in response to Item 4.01 on this Form 8-K, and has requested that L&W furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statement. A copy of the letter, dated December 3, 2019, is filed as Exhibit 16.1 to this Current Report on Form 8-K.

Engagement of M&K CPAS, PLLC

 

On December 2, 2019, the board of directors (the “Board”) of the Company approved the engagement of M&K CPAS, PLLC, as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2019.

During the fiscal years ended December 31, 2018 and December 31, 2017 and the subsequent interim period through December 2, 2019, the date of engagement of M&K, the Company did not consult with M&K regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (ii) any matter that was either the subject of a disagreement (as defined in paragraph (a)(1)(iv) of Item 304 of Regulation S-K and the related instructions thereto) or a reportable event (as described in paragraph (a)(1)(v) of Item 304 of Regulation S-K). 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

16.1 Liggett & Webb, P.A. dated December 3, 2019

  

 


BioSolar Inc Exhibit
EX-16.1 2 f8k120219ex16-1_biosolarinc.htm LIGGETT & WEBB,…
To view the full exhibit click here

Story continues below

About BIOSOLAR, INC. (OTCMKTS:BSRC)

BioSolar, Inc. is engaged in developing technologies and materials for storing electrical energy produced by photovoltaic solar modules. The Company offers BioBacksheet, a green back sheet for photovoltaic solar panels. BioBacksheet is a bottom layer of the conventional photovoltaic panels that provides electrical insulation, protection from the environment, and an increase in the panel output. It also focuses on the development of polymer-based components for supercapacitors and batteries. It offers bio-based components for thermal and durability requirements of solar module manufacturing processes. It also offers multiple versions of its bio-based back sheet. The mono-layer BioBacksheet version is designed for conventional crystalline silicon (c-Si) solar modules, as well as for certain thin film solar modules. These back sheets are available in rolls of film for direct use in lamination and roll-to-roll assembly systems. It uses Nylon 11 in its BioBacksheet.

An ad to help with our costs